A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

PHASE3RecruitingINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

January 31, 2028

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG

SHR-A1912 Injection

SHR-A1912 injection.

DRUG

Rituximab Injection

Rituximab injection.

DRUG

Gemcitabine Hydrochloride for Injection

Gemcitabine hydrochloride for injection.

DRUG

Oxaliplatin Injection

Oxaliplatin injection.

Trial Locations (1)

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors

lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY